His case work has involved cartel allegations in a variety of industries, alleged horizontal and vertical restraints by manufacturers in the technology and construction industries, antitrust claims against brand and generic drug manufacturers, and transfer pricing disputes. Prior to joining Analysis Group, Dr. Lewis was a manager in the economic and statistical consulting group of a financial advisory firm. Professor Baker is an expert in health care economics, including the effects of regulation on health care markets, physician market structure, the effects of managed care and insurance market competition on health care delivery and spending, and the determinants and impact of medical technology adoption. He has served as a consultant and advisor to health plans, government programs and public initiatives, and firms providing health care services and developing new health care products. Professor Baker’s research has been published in leading academic journals, including JAMA, The New England Journal of Medicine, American Economic Review, and the Journal of Health Economics. He is an elected member of the National Academy of Medicine and the recipient of the American Society of Health Economists’ ASHEcon Medal, which recognizes the top American health economists age 40 or under.
For more info regarding http://panarkadiko.eu/ns/index.php/2013-08-09-06-17-04/2014-04-08-06-32-51/2016-03-08-07-41-20/5739-telikes-texnikes-prodiagrafes-gia-eniaia-efarmogi- look at our own web-site.